References in this report to "we," "us" or the "Company" refer to Cartica
Acquisition Corp References to our "management" or our "management team" refer
to our officers and directors, and references to the "Sponsor" refer to Cartica
Acquisition Partners, LLC. The following discussion and analysis of the
Company's financial condition and results of operations should be read in
conjunction with the financial statements and the notes thereto contained
elsewhere in this report. Certain information contained in the discussion and
analysis set forth below includes forward-looking statements that involve risks
and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This report includes "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are
not historical facts and involve risks and uncertainties that could cause actual
results to differ materially from those expected and projected. All statements,
other than statements of historical fact included in this report including,
without limitation, statements in this "Management's Discussion and Analysis of
Financial Condition and Results of Operations" regarding the completion of the
Proposed Business Combination (as defined below), the Company's financial
position, business strategy and the plans and objectives of management for
future operations, are forward-looking statements. Words such as "expect,"
"believe," "anticipate," "intend," "estimate," "seek" and variations and similar
words and expressions are intended to identify such forward-looking statements.
Such forward-looking statements relate to future events or future performance,
but reflect management's current beliefs, based on information currently
available. A number of factors could cause actual events, performance or results
to differ materially from the events, performance and results discussed in the
forward-looking statements, including that the conditions of the Proposed
Business Combination are not satisfied. For information identifying important
factors that could cause actual results to differ materially from those
anticipated in the forward-looking statements, please refer to the Risk Factors
section of the Company's final prospectus for its Initial Public Offering filed
with the U.S. Securities and Exchange Commission (the "SEC"). The Company's
securities filings can be accessed on the EDGAR section of the SEC's website at
www.sec.gov. Except as expressly required by applicable securities law, the
Company disclaims any intention or obligation to update or revise any
forward-looking statements whether as a result of new information, future events
or otherwise.
Overview
Cartica Acquisition Corp was incorporated in the Cayman Islands on February 3,
2021. The Company was formed for the purpose of effecting a merger, share
exchange, asset acquisition, share purchase, reorganization or similar business
combination with one or more businesses. Our sponsor is Cartica Acquisition
Partners, LLC (the "Sponsor"), a Delaware limited liability company. The
registration statement for our IPO was declared effective on January 4, 2022. On
January 7, 2022, we consummated our IPO of 23,000,000 units, including 3,000,000
additional units to cover over-allotments, at $10.00 per unit, generating gross
proceeds of $230.0 million.
Simultaneously with the closing of the IPO, the Company completed the private
sale of an aggregate of 15,900,000 warrants ("Private Placement Warrants") to
the sponsor at a purchase price of $1.00 per Private Placement Warrant,
generating gross proceeds to the Company of $15,900,000.
At the closing of the IPO, management has agreed that an amount equal to at
least $10.30 per unit sold in the IPO, including proceeds from the sale of the
Private Placement Warrants, will be held in a trust account, located in the
United States and invested in U.S. government securities, within the meaning set
forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185
days or less or in any open-ended investment company that holds itself out as a
money market fund selected by the Company meeting certain conditions of Rule
2a-7 of the Investment Company Act, as determined by the Company, until the
earlier of (i) the completion of a business combination and (ii) the
distribution of the funds held in the trust account.
Our management has broad discretion with respect to the specific application of
the net proceeds of our IPO and the sale of the Private Placement Warrants,
although substantially all of the net proceeds are intended to be applied
generally toward consummating our initial business combination.
21
Table of Contents
We have until 18 months from the closing of our IPO, or July 7, 2023, or during
one of the two three-month periods by which we may extend such deadline, without
holders of public shares being entitled to vote or redeem their shares in
connection with such extensions, if our sponsor or any of its affiliates or
designees pays an additional $0.10 per public share into the trust account in
respect of each such extension period (for a total of up to 24 months to
complete a business combination) or a shareholder vote to amend our amended and
restated memorandum and articles of association, to complete a business
combination (the "Combination Period"). If we have not completed a business
combination within the Combination Period, we will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as reasonably possible,
but not more than ten business days thereafter, redeem the public shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit
in the trust account including interest earned on the funds held in the trust
account and not previously released to the Company to pay its tax obligations
(less taxes payable and up to $100,000 of interest to pay dissolution expenses
and which interest shall be net of taxes payable), divided by the number of then
issued and outstanding public shares, which redemption will completely
extinguish public shareholders' rights as shareholders (including the right to
receive further liquidating distributions, if any), and (iii) as promptly as
reasonably possible following such redemption, subject to the approval of the
Company's remaining shareholders and the Company's board of directors, dissolve
and liquidate, subject in each case to the Company's obligations under Cayman
Islands law to provide for claims of creditors and the requirements of other
applicable law. There will be no redemption rights or liquidating distributions
with respect to the Company's warrants, which will expire worthless if the
Company fails to complete a business combination within the Combination Period.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date.
Our only activities from February 3, 2021 (inception) through March 31, 2022
were organizational activities, those necessary to prepare for the IPO,
described below, and identifying a target company for a Business Combination. We
do not expect to generate any operating revenues until after the completion of
our Business Combination. We generate non-operating income in the form of
interest income on marketable securities held in the Trust Account. We incur
expenses as a result of being a public company (for legal, financial reporting,
accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended March 31, 2022, we had a net income of $6,650,368,
which consists of operating costs of $965,893 and transaction costs of $378,343,
offset by the change in fair value of warrant liabilities of $7,867,560 and
interest income on marketable securities held in the Trust Account of $127,044.
For the period from February 3, 2021 (inception) through March 31, 2021, we had
net loss $3,933 which consisted of formation and operating costs.
Liquidity and Capital Resources
On January 7, 2022, we completed the sale of 23,000,000 Units at a price of
$10.00 per Unit, generating gross proceeds to the Company of $230,000,000.
Simultaneously with the closing of the IPO, we completed the private sale of an
aggregate of 15,900,000 Private Placement Warrants at a purchase price of $1.00
per Private Placement Warrant, generating gross proceeds to the Company of
$15,900,000
For the three months ended March 31, 2022, cash used in operating activities was
$1,868,357. Net income of $6,650,368 was affected by interest earned on
marketable securities held in the Trust Account of $127,044, transaction costs
of $378,343 and change in fair value of warrant liabilities of $7,867,560.
Changes in operating assets and liabilities used $902,464 of cash for operating
activities.
For the period from February 3, 2021 (inception) through March 31, 2021, cash
used in operating activities was $143. Net loss of $3,933 was affected by
changes in operating assets and liabilities which provided $3,790 of cash for
operating activities.
As of March 31, 2022, we had marketable securities held in the Trust Account of
$237,027,044 (including $127,044 of interest income) consisting of U.S. Treasury
Bills with a maturity of 185 days or less. We may withdraw interest from the
Trust Account to pay taxes, if any. We intend to use substantially all of the
funds held in the Trust Account, including any amounts representing interest
earned on the Trust Account (less income taxes payable), to complete our
Business Combination. To the extent that our share capital or debt is used, in
whole or in part, as consideration to complete our Business Combination, the
remaining proceeds held in the Trust Account will be
22
Table of Contents
used as working capital to finance the operations of the target business or
businesses, make other acquisitions and pursue our growth strategies.
As of March 31, 2022, we had cash of $1,910,288. We intend to use the funds held
outside the Trust Account primarily to identify and evaluate target businesses,
perform business due diligence on prospective target businesses, travel to and
from the offices, plants or similar locations of prospective target businesses
or their representatives or owners, review corporate documents and material
agreements of prospective target businesses, structure, negotiate and complete a
Business Combination.
In order to fund working capital deficiencies or finance transaction costs in
connection with a Business Combination, the Sponsor, or certain of our officers
and directors or their affiliates may, but are not obligated to, loan us funds
as may be required. If we complete a Business Combination, we would repay such
loaned amounts. In the event that a Business Combination does not close, we may
use a portion of the working capital held outside the Trust Account to repay
such loaned amounts but no proceeds from our Trust Account would be used for
such repayment. Up to $2,000,000 of such loans may be convertible into warrants
at a price of $1.00 per warrant, at the option of the lender. The warrants would
be identical to the Private Placement Warrants.
We do not believe we will need to raise additional funds in order to meet the
expenditures required for operating our business. However, if our estimate of
the costs of identifying a target business, undertaking in-depth due diligence
and negotiating a Business Combination are less than the actual amount necessary
to do so, we may have insufficient funds available to operate our business prior
to our initial Business Combination. Moreover, we may need to obtain additional
financing either to complete our Business Combination or because we become
obligated to redeem a significant number of our public shares upon completion of
our Business Combination, in which case we may issue additional securities or
incur debt in connection with such Business Combination.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered
off-balance sheet arrangements as of March 31, 2022. We do not participate in
transactions that create relationships with unconsolidated entities or financial
partnerships, often referred to as variable interest entities, which would have
been established for the purpose of facilitating off-balance sheet arrangements.
We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of
other entities, or purchased any non-financial assets.
Contractual Obligations
On January 4, 2022, we entered into an agreement to pay our Sponsor $930,000
over eighteen months beginning at the closing of the Initial Public Offering,
for the following administrative support expenses: (i) cash compensation to Mr.
Goel, our Chief Executive Officer, in the form of an annual salary of $312,000;
(ii) cash compensation to Mr. Coad, our Chief Operating Officer and Chief
Financial Officer, in the form of an annual salary of $200,000; and (iii) $9,000
per month for office space, utilities and research, analytical, secretarial and
administrative support, which the Sponsor is expected to source principally from
Cartica Management, LLC ("Cartica Management"). In addition, at the closing of
the Initial Public Offering, we paid the Sponsor an aggregate amount of $601,167
of which $549,000 represented compensation and bonuses paid to Mr. Goel and Mr.
Coad for their services through the closing of the Initial Public Offering and
$51,667 represented a prepayment of administrative support expenses for January
2022, to be amortized over the service period. Upon completion of a Business
Combination or our liquidation, we will cease paying these amounts (in the case
of the officer compensation, after 30 days' notice). As of December 31, 2021 we
had accrued $238,000 of officer compensation payable to the Sponsor under the
administrative support agreement. For the three months ended March 31, 2022, we
incurred $466,500 in fees for these services and paid $704,500 of fees for these
services.
We granted the underwriters a 45-day option from the date of the IPO to purchase
up to 3,000,000 additional Units to cover over-allotments, if any, at the IPO
price less the underwriting discounts and commissions. As of January 7, 2022,
the over-allotment was fully exercised.
The underwriters received a cash underwriting discount of $0.20 per Unit, or
$4,600,000 in the aggregate (which included an additional $600,000 received
pursuant to the full exercise of the over-allotment option), which was paid at
closing of the IPO. In addition, the underwriters are entitled to a deferred fee
of $0.35 per Unit, or $8,050,000 in the aggregate (which included an additional
$1,050,000 received pursuant to the full exercise of the over-allotment option).
The deferred fee will become payable to the underwriters from the
23
Table of Contents
amounts held in the Trust Account solely in the event that the Company completes
a Business Combination, subject to the terms of the underwriting agreement.
We entered into a forward purchase agreement with Cartica Investors, LP and
Cartica Investors II, LP, two private funds that are affiliates of Cartica
Management and the Sponsor (the "Cartica Funds"), pursuant to which the Cartica
Funds will agree to subscribe for an aggregate of up to 3,000,000 forward
purchase shares for $10.00 per share, or up to $30,000,000 in the aggregate, in
a private placement to close substantially concurrently with the closing of our
initial Business Combination, subject to approval at such time by the Cartica
Management investment committee. Under the forward purchase agreement, the
purchase investors (i) must vote any Class A ordinary shares owned by them at
the time of any shareholder vote to approve a proposed business combination in
favor of such proposed business combination, and (ii) are entitled to
registration rights with respect to the forward purchase shares and any other
Class A ordinary shares acquired by the forward purchase investors, including
any acquired subsequent to the completion of our initial business combination.
The proceeds from the sale of the forward purchase shares may be used as part of
the consideration to the sellers in our initial Business Combination, expenses
in connection with our initial Business Combination or for working capital in
the post-business combination company. These purchases will be required to be
made regardless of whether any Class A ordinary shares are redeemed by our
public shareholders. The forward purchase shares will be issued only in
connection with the closing of the initial business combination.
Critical Accounting Estimates
The preparation of condensed financial statements and related disclosures in
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities, disclosure of contingent assets and
liabilities at the date of the financial statements, and income and expenses
during the periods reported. Actual results could materially differ from those
estimates. We have identified the following critical accounting estimates:
Warrant Liabilities
A critical accounting estimate made in our financial statements is the estimated
fair value of our warrant liabilities. The fair value of our financial assets
and liabilities reflects management's estimate of amounts that we would have
received in connection with the sale of the assets or paid in connection with
the transfer of the liabilities in an orderly transaction between market
participants at the measurement date. In connection with measuring the fair
value of its assets and liabilities, we seek to maximize the use of observable
inputs (market data obtained from independent sources) and to minimize the use
of unobservable inputs (internal assumptions about how market participants would
price assets and liabilities). The following fair value hierarchy is used to
classify assets and liabilities based on the observable inputs and unobservable
inputs used in order to value the assets and liabilities:
Level 1, Valuations based on unadjusted quoted prices in active markets for
identical assets or liabilities that the Company has the ability to access.
? Valuation adjustments and block discounts are not being applied. Since
valuations are based on quoted prices that are readily and regularly available
in an active market, valuation of these securities does not entail a
significant degree of judgment.
Level 2, Valuations based on (i) quoted prices in active markets for similar
assets and liabilities, (ii) quoted prices in markets that are not active for
? identical or similar assets, (iii) inputs other than quoted prices for the
assets or liabilities, or (iv) inputs that are derived principally from or
corroborated by market through correlation or other means.
? Level 3, Valuations based on inputs that are unobservable and significant to
the overall fair value measurement.
As of March 31, 2022, we had 27,400,000 warrants issued and outstanding.
Recent Accounting Standards
In August 2020, the FASB issued ASU 2020-06, Debt - "Debt with Conversion and
Other Options" (Subtopic 470-20) and "Derivatives and Hedging - Contracts in
Entity's Own Equity" (Subtopic 815-40) ("ASU 2020-06") to simplify accounting
for certain financial instruments. ASU 2020-06 eliminates the current models
that require separation of beneficial conversion and cash conversion features
from convertible instruments and simplifies the derivative scope exception
guidance pertaining to equity classification of contracts in
24
Table of Contents
an entity's own equity. The new standard also simplifies the diluted earnings
per share calculation in certain areas and introduces additional disclosures for
convertible debt and freestanding instruments that are indexed to and settled in
an entity's own equity. ASU 2020-06 amends the diluted earnings per share
guidance, including the requirement to use the if-converted method for all
convertible instruments. ASU 2020-06 is effective for fiscal years beginning
after December 15, 2023, including interim periods within those fiscal years,
with early adoption permitted. The Company is currently assessing the impact, if
any, that ASU 2020-06 would have on its financial position, results of
operations or cash flows.
Management does not believe that any other recently issued, but not yet
effective, accounting standards, if currently adopted, would have a material
effect on our condensed financial statements.
© Edgar Online, source Glimpses
CARTICA ACQUISITION CORP 
